This statistic shows the sales value of outpatient prescription drugs for benign prostatic hyperplasia (BPH) in South Korea in 2016, by age group. In 2016, the BPH medication sales for patients aged between 70 and 79 years amounted to over 92 billion South Korean won.
Sales value of outpatient prescription drugs for benign prostatic hyperplasia (BPH) in South Korea in 2016, by age group
(in billion South Korean won)
Characteristic
Sales value in billion South Korean won
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
KHIDI. (February 6, 2018). Sales value of outpatient prescription drugs for benign prostatic hyperplasia (BPH) in South Korea in 2016, by age group (in billion South Korean won) [Graph]. In Statista. Retrieved August 25, 2024, from https://www.statista.com/statistics/863824/south-korea-prostatic-hyperplasia-outpatient-prescription-drug-sales-by-age-group/
KHIDI. "Sales value of outpatient prescription drugs for benign prostatic hyperplasia (BPH) in South Korea in 2016, by age group (in billion South Korean won)." Chart. February 6, 2018. Statista. Accessed August 25, 2024. https://www.statista.com/statistics/863824/south-korea-prostatic-hyperplasia-outpatient-prescription-drug-sales-by-age-group/
KHIDI. (2018). Sales value of outpatient prescription drugs for benign prostatic hyperplasia (BPH) in South Korea in 2016, by age group (in billion South Korean won). Statista. Statista Inc.. Accessed: August 25, 2024. https://www.statista.com/statistics/863824/south-korea-prostatic-hyperplasia-outpatient-prescription-drug-sales-by-age-group/
KHIDI. "Sales Value of Outpatient Prescription Drugs for Benign Prostatic Hyperplasia (Bph) in South Korea in 2016, by Age Group (in Billion South Korean Won)." Statista, Statista Inc., 6 Feb 2018, https://www.statista.com/statistics/863824/south-korea-prostatic-hyperplasia-outpatient-prescription-drug-sales-by-age-group/
KHIDI, Sales value of outpatient prescription drugs for benign prostatic hyperplasia (BPH) in South Korea in 2016, by age group (in billion South Korean won) Statista, https://www.statista.com/statistics/863824/south-korea-prostatic-hyperplasia-outpatient-prescription-drug-sales-by-age-group/ (last visited August 25, 2024)
Sales value of outpatient prescription drugs for benign prostatic hyperplasia (BPH) in South Korea in 2016, by age group (in billion South Korean won) [Graph], KHIDI, February 6, 2018. [Online]. Available: https://www.statista.com/statistics/863824/south-korea-prostatic-hyperplasia-outpatient-prescription-drug-sales-by-age-group/